Cargando…
Molnupiravir When Used Alone Seems to Be Safe and Effective as Outpatient COVID-19 Therapy for Hemodialyzed Patients and Kidney Transplant Recipients
Background: Molnupiravir demonstrated an in vitro antiviral activity against positive-sense RNA viruses, including SARS-CoV-2. The study aimed to present the results of outpatient molnupiravir use in kidney transplant recipients and hemodialysis patients during the first months of 2022 in Poland. Me...
Autores principales: | Poznański, Paweł, Augustyniak-Bartosik, Hanna, Magiera-Żak, Anna, Skalec, Karolina, Jakuszko, Katarzyna, Mazanowska, Oktawia, Janczak, Dariusz, Krajewska, Magdalena, Kamińska, Dorota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610487/ https://www.ncbi.nlm.nih.gov/pubmed/36298779 http://dx.doi.org/10.3390/v14102224 |
Ejemplares similares
-
Comparing Humoral and Cellular Adaptive Immunity during Convalescent Phase of COVID-19 in Hemodialysis Patients and Kidney Transplant Recipients
por: Kamińska, Dorota, et al.
Publicado: (2021) -
Post-transplant lymphoproliferative disorder in adult renal transplant recipients: case series and review of literature
por: Kamińska, Dorota, et al.
Publicado: (2021) -
The attitude of kidney transplant recipients towards elective arteriovenous fistula ligation
por: Bardowska, Klaudia, et al.
Publicado: (2020) -
The impact of location and patency of the arteriovenous fistula on quality of life of kidney transplant recipients
por: Letachowicz, Krzysztof, et al.
Publicado: (2021) -
Is a Patient with Paget’s Disease of Bone Suitable for Living Kidney Donation?—Decision-Making in Lack of Clinical Evidence
por: Poznański, Paweł, et al.
Publicado: (2022)